Inventor · disambiguated record
Mirko Hennig
Also filed as: HENNIG MIRKO
7 granted patents·20 pending applications·17 citations·filing 2018–2024
82Inventor score
Top patents by PatentIndex Score
27 records- 0194US11786610B2Treatment of primary ciliary dyskinesia with synthetic messenger RNATRANSCRIPTX INC·Filed 2022·Granted Oct 17, 2023·4 cites·20 claims
- 0294US11510997B2Treatment of primary ciliary dyskinesia with synthetic messenger RNATRANSCRIPTX INC·Filed 2022·Granted Nov 29, 2022·5 cites·26 claims
- 0390US12121610B2Compositions and methods for targeted delivery to cellsRECODE THERAPEUTICS INC·Filed 2023·Granted Oct 22, 2024·3 cites·32 claims
- 0490US11642421B2Treatment of primary ciliary dyskinesia with synthetic messenger RNATRANSCRIPTX INC·Filed 2020·Granted May 9, 2023·2 cites·65 claims
- 0589US12133923B2Lipid nanoparticle compositions and uses thereofRECODE THERAPEUTICS INC·Filed 2024·Granted Nov 5, 2024·2 cites·25 claims
- 0688US12337068B2Lipid nanoparticle compositions and uses thereofRECODE THERAPEUTICS INC·Filed 2024·Granted Jun 24, 2025·1 cites·28 claims
- 0782US2024374513A1Compositions and methods for targeted delivery to cellsRECODE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0882US2024374514A1Compositions and methods for targeted delivery to cellsRECODE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0982US2024390271A1Compositions and methods for targeted delivery to cellsRECODE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1082US2024374512A1Compositions and methods for targeted delivery to cellsRECODE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1182US2024390272A1Compositions and methods for targeted delivery to cellsRECODE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1282US2024374511A1Compositions and methods for targeted delivery to cellsRECODE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1381US2024285798A1Treatment of primary ciliary dyskinesia with synthetic messenger rnaTRANSCRIPTX INC·Filed 2023·Application pending·0 cites
- 1480US12257318B2Polynucleotide compositions, related formulations, and methods of use thereofRECODE THERAPEUTICS INC·Filed 2024·Granted Mar 25, 2025·0 cites·30 claims
- 1579US2025276091A1Polynucleotide compositions, related formulations, and methods of use thereofRECODE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1679US2023338411A1Compositions and methods for targeted delivery to cellsRECODE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1779US2024299310A1Polynucleotide compositions, related formulations, and methods of use thereofRECODE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1879US2024277850A1Polynucleotide compositions, related formulations, and methods of use thereofRECODE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1979US2024261432A1Polynucleotide compositions, related formulations, and methods of use thereofRECODE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2078US2024245619A1Polynucleotide compositions, related formulations, and methods of use thereofRECODE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2175US2024207178A1Compositions and methods for targeted delivery to cellsRECODE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2272US2024398983A1Polynucleotide compositions, related formulations, and methods of use thereofRECODE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2370US2019117796A1Treatment of primary ciliary dyskinesia with synthetic messenger rnaTRANSCRIPTX INC·Filed 2018·Application pending·0 cites
- 2470US2019111074A1Treatment of primary ciliary dyskinesia with synthetic messenger rnaTRANSCRIPTX INC·Filed 2018·Application pending·0 cites
- 2568US2025019409A1Polynucleotide compositions, related formulations, and methods of use thereofRECODE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2655US2025114477A1Polynucleotide compositions, related formulations, and methods of use thereofRECODE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2753US2024123087A1Polynucleotide compositions, related formulations, and methods of use thereofRECODE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mirko Hennig files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →